Sort
130,381 grants matching “hiv”
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$1,008,085Tracy M Handel · University Of California, San Diego · U01 · FY2010 · GM
High Risk Drug Use &HIV-Learning from the NYC Epidemic
$1,007,957National Development &Res Institutes · P30 · FY2005 · DA
Clinical Trials of Patients with AIDS-Related Malignancies
$1,007,955Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,007,817Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Cognitive Function, Alzheimer's Disease and Related Disorders in the HAALSI Cohort
$1,007,808Lisa F Berkman · Harvard School Of Public Health · R01 · FY2021 · AG
PEDIATRIC AIDS CLINICAL TRIALS UNIT
$1,007,797New York University School Of Medicine · U01 · FY2000 · AI
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$1,007,764Myron S Cohen · Family Health International · UM1 · FY2023 · AI
Induction of protective t-cell responses to HIV-1
$1,007,730Andrew James McMichael · Duke University · UM1 · FY2016 · AI
MUCOSAL IMMUNITY AND INFECTION
$1,007,539Case Western Reserve University · P01 · FY2003 · AI
Fibrotic Sequelae of Childhood Renal Disease
$1,007,507Agnes B Fogo · Vanderbilt University · P50 · FY2006 · DK
Structural Biology Core
$1,007,249Dmitry Lyumkis · Seattle Children'S Hospital · U54 · FY2024 · AI
SFGH AIDS MALIGNANCY BANK
$1,007,195University Of California San Francisco · U01 · FY2000 · CA
Laboratory Support
$1,007,157Wendy Stevens · Wits Health Consortium (Pty), Ltd · U19 · FY2009 · AI
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
$1,007,048Adam Wayne Carrico · Florida International University · R01 · FY2025 · MH
Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS
$1,006,998Teresa Stephens · South Carolina Department Of Public Health · U62 · FY2014 · PS
Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS
$1,006,998Teresa Stephens · South Carolina Department Of Public Health · U62 · FY2015 · PS
Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH
$1,006,870Fakhrul Ahsan · Vascular Biosciences · R42 · FY2022 · HL
Development of Inhaled CPZEN-45 For Tuberculosis Therapy
$1,006,759Anthony James Hickey · Research Triangle Institute · R01 · FY2019 · AI
Integrating tobacco use cessation into HIV Care and Treatment in Ministry of Health Facilities in Kisumu County, Kenya
$1,006,744Stella Aguinaga Bialous · University Of California, San Francisco · U01 · FY2025 · CA
Artherosclerosis/bone loss/drug use/HIV in older men
$1,006,713Montefiore Medical Center (Bronx, Ny) · R01 · FY2004 · DA
Theoretically Based Mobile App to Increase PrEP Uptake Among MSM
$1,006,691Patrick Sean Sullivan · Emory University · R01 · FY2018 · DA
The small intestinal microbiota in undernourished women and undernourished children in Bangladesh: identifying causal mechanisms and therapeutic targets
$1,006,591Jeffrey Ivan Gordon · Washington University · R01 · FY2022 · DK
Human Mitochondrial Dna Polymerase With Anti-hiv Nucleotides
$1,006,586William Copeland · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Assembly, maturation, and structures of HIV Gag, Gag-Pol and Pol, and PFV polyproteins
$1,006,545Bruce Edward Torbett · Scripps Research Institute, The · U54 · FY2018 · GM
Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM)
$1,006,417C. Hendricks Brown · Northwestern University At Chicago · P30 · FY2017 · DA